A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn if outpatients with bipolar mania who
are partially nonresponsive to lithium or valproate monotherapy can achieve stable symptoms
on a combination treatment of aripiprazole plus lithium or valproate.
Phase:
Phase 4
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.